Home Applications 214876 Application 214876
Type NDA
Sponsor GLAXOSMITHKLINE Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 ZEJULA NIRAPARIB TOSYLATE TABLET;ORAL EQ 100MG BASE Yes No 002 ZEJULA NIRAPARIB TOSYLATE TABLET;ORAL EQ 200MG BASE Yes No 003 ZEJULA NIRAPARIB TOSYLATE TABLET;ORAL EQ 300MG BASE Yes Yes
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 3 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N214876-001 ZEJULA NIRAPARIB TOSYLATE EQ 100MG BASE TABLET / ORAL RLD 2023-04-26 N214876-002 ZEJULA NIRAPARIB TOSYLATE EQ 200MG BASE TABLET / ORAL RLD 2023-04-26 N214876-003 ZEJULA NIRAPARIB TOSYLATE EQ 300MG BASE TABLET / ORAL RLD, RS 2023-04-26
Orange Book patents# Current patent rows page 1 of 1 · 27 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N214876-001 8071579 2027-08-12 U-2655 2023-05-23 N214876-001 8143241 2027-08-12 U-2655 2023-05-23 N214876-001 8436185 2029-04-24 Drug substance 2023-05-23 N214876-001 8071623 2031-03-27 Drug substance, Drug product 2023-05-23 N214876-001 8859562 2031-08-04 U-2655 2023-05-23 N214876-001 11091459 2038-03-27 Drug product 2023-05-23 N214876-001 11673877 2038-03-27 U-3646 Drug product 2023-07-11 N214876-001 11673877 2038-03-27 U-3647 Drug product 2023-07-11 N214876-001 11730725 2039-01-25 Drug product 2023-09-21 N214876-002 8071579 2027-08-12 U-2655 2023-05-23 N214876-002 8143241 2027-08-12 U-2655 2023-05-23 N214876-002 8436185 2029-04-24 Drug substance 2023-05-23 N214876-002 8071623 2031-03-27 Drug substance, Drug product 2023-05-23 N214876-002 8859562 2031-08-04 U-2655 2023-05-23 N214876-002 11091459 2038-03-27 Drug product 2023-05-23 N214876-002 11673877 2038-03-27 U-3646 Drug product 2023-07-11 N214876-002 11673877 2038-03-27 U-3647 Drug product 2023-07-11 N214876-002 11730725 2039-01-25 Drug product 2023-09-21 N214876-003 8071579 2027-08-12 U-2655 2023-05-23 N214876-003 8143241 2027-08-12 U-2655 2023-05-23 N214876-003 8436185 2029-04-24 Drug substance 2023-05-23 N214876-003 8071623 2031-03-27 Drug substance, Drug product 2023-05-23 N214876-003 8859562 2031-08-04 U-2655 2023-05-23 N214876-003 11091459 2038-03-27 Drug product 2023-05-23 N214876-003 11673877 2038-03-27 U-3646 Drug product 2023-07-11 N214876-003 11673877 2038-03-27 U-3647 Drug product 2023-07-11 N214876-003 11730725 2039-01-25 Drug product 2023-09-21
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 66 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N214876-001 ZEJULA EQ 100MG BASE TABLET / ORAL RLD 2023-04-26 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N214876-002 ZEJULA EQ 200MG BASE TABLET / ORAL RLD 2023-04-26 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N214876-003 ZEJULA EQ 300MG BASE TABLET / ORAL RLD, RS 2023-04-26 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N214876-001 ZEJULA EQ 100MG BASE TABLET / ORAL RLD 2023-04-26 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N214876-002 ZEJULA EQ 200MG BASE TABLET / ORAL RLD 2023-04-26 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N214876-003 ZEJULA EQ 300MG BASE TABLET / ORAL RLD, RS 2023-04-26 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N214876-001 ZEJULA EQ 100MG BASE TABLET / ORAL RLD 2023-04-26 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N214876-002 ZEJULA EQ 200MG BASE TABLET / ORAL RLD 2023-04-26 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N214876-003 ZEJULA EQ 300MG BASE TABLET / ORAL RLD, RS 2023-04-26 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N214876-001 ZEJULA EQ 100MG BASE TABLET / ORAL RLD 2023-04-26 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N214876-002 ZEJULA EQ 200MG BASE TABLET / ORAL RLD 2023-04-26 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N214876-003 ZEJULA EQ 300MG BASE TABLET / ORAL RLD, RS 2023-04-26 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N214876-001 ZEJULA EQ 100MG BASE TABLET / ORAL RLD 2023-04-26 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N214876-002 ZEJULA EQ 200MG BASE TABLET / ORAL RLD 2023-04-26 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N214876-003 ZEJULA EQ 300MG BASE TABLET / ORAL RLD, RS 2023-04-26 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N214876-001 ZEJULA EQ 100MG BASE TABLET / ORAL RLD 2023-04-26 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N214876-002 ZEJULA EQ 200MG BASE TABLET / ORAL RLD 2023-04-26 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N214876-003 ZEJULA EQ 300MG BASE TABLET / ORAL RLD, RS 2023-04-26 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N214876-001 ZEJULA EQ 100MG BASE TABLET / ORAL RLD 2023-04-26 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N214876-002 ZEJULA EQ 200MG BASE TABLET / ORAL RLD 2023-04-26 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N214876-003 ZEJULA EQ 300MG BASE TABLET / ORAL RLD, RS 2023-04-26 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N214876-001 ZEJULA EQ 100MG BASE TABLET / ORAL RLD 2023-04-26 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N214876-002 ZEJULA EQ 200MG BASE TABLET / ORAL RLD 2023-04-26 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N214876-003 ZEJULA EQ 300MG BASE TABLET / ORAL RLD, RS 2023-04-26 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N214876-001 ZEJULA EQ 100MG BASE TABLET / ORAL RLD 2023-04-26 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N214876-002 ZEJULA EQ 200MG BASE TABLET / ORAL RLD 2023-04-26 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N214876-003 ZEJULA EQ 300MG BASE TABLET / ORAL RLD, RS 2023-04-26 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N214876-001 ZEJULA EQ 100MG BASE TABLET / ORAL RLD 2023-04-26 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N214876-002 ZEJULA EQ 200MG BASE TABLET / ORAL RLD 2023-04-26 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N214876-003 ZEJULA EQ 300MG BASE TABLET / ORAL RLD, RS 2023-04-26 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N214876-001 ZEJULA EQ 100MG BASE TABLET / ORAL RLD 2023-04-26 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N214876-002 ZEJULA EQ 200MG BASE TABLET / ORAL RLD 2023-04-26 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N214876-003 ZEJULA EQ 300MG BASE TABLET / ORAL RLD, RS 2023-04-26 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N214876-001 ZEJULA EQ 100MG BASE TABLET / ORAL RLD 2023-04-26 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N214876-002 ZEJULA EQ 200MG BASE TABLET / ORAL RLD 2023-04-26 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N214876-003 ZEJULA EQ 300MG BASE TABLET / ORAL RLD, RS 2023-04-26 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N214876-001 ZEJULA EQ 100MG BASE TABLET / ORAL RLD 2023-04-26 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N214876-002 ZEJULA EQ 200MG BASE TABLET / ORAL RLD 2023-04-26 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N214876-003 ZEJULA EQ 300MG BASE TABLET / ORAL RLD, RS 2023-04-26 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N214876-001 ZEJULA EQ 100MG BASE TABLET / ORAL RLD 2023-04-26 8072bd15b7f6…
Observed Orange Book patent history# Patent history page 1 of 15 · 582 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N214876-001 8071579 2027-08-12 U-2655 2023-05-23 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N214876-001 8143241 2027-08-12 U-2655 2023-05-23 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N214876-001 8436185 2029-04-24 Drug substance 2023-05-23 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N214876-001 8071623 2031-03-27 Drug substance, Drug product 2023-05-23 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N214876-001 8859562 2031-08-04 U-2655 2023-05-23 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N214876-001 11091459 2038-03-27 Drug product 2023-05-23 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N214876-001 11673877 2038-03-27 U-3646 Drug product 2023-07-11 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N214876-001 11673877 2038-03-27 U-3647 Drug product 2023-07-11 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N214876-001 11730725 2039-01-25 Drug product 2023-09-21 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N214876-002 8071579 2027-08-12 U-2655 2023-05-23 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N214876-002 8143241 2027-08-12 U-2655 2023-05-23 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N214876-002 8436185 2029-04-24 Drug substance 2023-05-23 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N214876-002 8071623 2031-03-27 Drug substance, Drug product 2023-05-23 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N214876-002 8859562 2031-08-04 U-2655 2023-05-23 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N214876-002 11091459 2038-03-27 Drug product 2023-05-23 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N214876-002 11673877 2038-03-27 U-3647 Drug product 2023-07-11 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N214876-002 11673877 2038-03-27 U-3646 Drug product 2023-07-11 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N214876-002 11730725 2039-01-25 Drug product 2023-09-21 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N214876-003 8071579 2027-08-12 U-2655 2023-05-23 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N214876-003 8143241 2027-08-12 U-2655 2023-05-23 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N214876-003 8436185 2029-04-24 Drug substance 2023-05-23 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N214876-003 8071623 2031-03-27 Drug substance, Drug product 2023-05-23 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N214876-003 8859562 2031-08-04 U-2655 2023-05-23 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N214876-003 11091459 2038-03-27 Drug product 2023-05-23 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N214876-003 11673877 2038-03-27 U-3647 Drug product 2023-07-11 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N214876-003 11673877 2038-03-27 U-3646 Drug product 2023-07-11 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N214876-003 11730725 2039-01-25 Drug product 2023-09-21 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N214876-001 8071579 2027-08-12 U-2655 2023-05-23 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N214876-001 8143241 2027-08-12 U-2655 2023-05-23 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N214876-001 8436185 2029-04-24 Drug substance 2023-05-23 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N214876-001 8071623 2031-03-27 Drug substance, Drug product 2023-05-23 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N214876-001 8859562 2031-08-04 U-2655 2023-05-23 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N214876-001 11091459 2038-03-27 Drug product 2023-05-23 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N214876-001 11673877 2038-03-27 U-3646 Drug product 2023-07-11 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N214876-001 11673877 2038-03-27 U-3647 Drug product 2023-07-11 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N214876-001 11730725 2039-01-25 Drug product 2023-09-21 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N214876-002 8071579 2027-08-12 U-2655 2023-05-23 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N214876-002 8143241 2027-08-12 U-2655 2023-05-23 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N214876-002 8436185 2029-04-24 Drug substance 2023-05-23 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N214876-002 8071623 2031-03-27 Drug substance, Drug product 2023-05-23 31067a03dcf5…
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join ZEJULA NIRAPARIB GlaxoSmithKline LLC b7f675e2-159c-490c-b6f4-3f16d9492b7d 2026-07-28 Warnings, Adverse reactions Exact identifier application applno (NDA): 214876 application number: NDA214876
Documents# Document, Submission type, Date table Document Submission type Date 85603 SUPPL 2026-03-31 85602 SUPPL 2026-03-31 83093 SUPPL 2025-08-12 82890 SUPPL 2025-07-21 82889 SUPPL 2025-07-21 82621 SUPPL 2025-06-20 82620 SUPPL 2025-06-20 82612 SUPPL 2025-06-20 82611 SUPPL 2025-06-20 76589 ORIG 2023-11-16 74100 ORIG 2023-04-27 74093 ORIG 2023-04-27